Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 cells in vitro

Molecules

Volumn 20, Issue 6, 2015, Pages 11524-11534

  Zhang, Jian Ye ^a,b   Lin, Min Ting ^b   Zhou, Meng Jia ^a   Yi, Tao ^a   Tang, Yi Na ^a   Tang, Si Li ^b   Yang, Zhi Jun ^a   Zhao, Zhong Zhen ^a   Chen, Hu Biao ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AKT; Apoptosis; Combined effect; Curcumin; ERK; Quercetin

Indexed keywords

CURCUMIN; LIPOCORTIN 5; PROTEIN KINASE B; QUERCETIN;

APOPTOSIS; BIOSYNTHESIS; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANNEXIN A5; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; STOMACH NEOPLASMS;

EID: 84938407776     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules200611524     Document Type: Article

References (18)

1. Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA-Cancer J. Clin. 2015, 65, 87-108.
2. He, A.B.; Peng, X.L.; Song, J.; Zhang, J.X.; Dong, W.G.; Luo, R.F.; Tang, Y. Efficacy of S-1 vs capecitabine for the treatment of gastric cancer: A meta-analysis. World J. Gastroenterol. 2015, 21, 4358-4364.
3. Kunnumakkara, A.B.; Anand, P.; Aggarwal, B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008, 269, 199-225.
4. Yang, K.Y.; Lin, L.C.; Tseng, T.Y.; Wang, S.C.; Tsai, T.H. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 853, 183-189.
5. Liu, A.; Lou, H.; Zhao, L.; Fan, P. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J. Pharm. Biomed. Anal. 2006, 40, 720-727.
6. Alexander, A.; Qureshi, A.; Kumari, L.; Vaishnav, P.; Sharma, M.; Saraf, S.; Saraf, S. Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients. Fitoterapia 2014, 97, 1-14.
7. Kim, H.G.; Lee, J.H.; Lee, S.J.; Oh, J.H.; Shin, E.; Jang, Y.P.; Lee, Y.J. The increased cellular uptake and biliary excretion of curcumin by quercetin: a possible role of albumin binding interaction. Drug Metab. Dispos. 2012, 40, 1452-1455.
8. Grill, A.E.; Koniar, B.; Panyam, J. Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin. Drug Deliv. Transl. Res. 2014, 4, 344-352.
9. Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003, 23, 363-398.
10. Zhang, J.Y.; Yi, T.; Liu, J.; Zhao, Z.Z.; Chen, H.B. Quercetin Induces Apoptosis via the Mitochondrial Pathway in KB and KBv200 Cells. J. Agric. Food. Chem. 2013, 61, 2188-2195.
11. Li-Weber, M. Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett. 2013, 332, 304-312.
12. Burz, C.; Berindan-Neagoe, I.; Balacescu, O.; Irimie, A. Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Acta Oncol. 2009, 48, 811-821.
13. Aggarwal, B.B.; Surh, Y.H.; Shishodia, S. The Molecular Targets and Therapeutics of Curcumin in Health and Disease. In Advances in Experimental Medicine and Biology; Springer Science & Business Media: Heidelberg, Germany, 2007; volume 995.
14. De Luca, A.; Maiello, M.R.; D'Alessio, A.; Pergameno, M.; Normanno, N. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin. Ther. Tar. 2012, 16, S17-S27.
15. Zhang, J.Y.; Tao, L.Y.; Liang, Y.J.; Yan, Y.Y.; Dai, C.L.; Xia, X.K.; She, Z.G.; Lin, Y.C.; Fu, L.W. Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G(1) with involvement of GSK-3beta/beta-catenin/c-Myc pathway. Cell Cycle 2009, 8, 2444-2450.
16. Zhang, J.Y.; Tao, L.Y.; Liang, Y.J.; Chen, L.M.; Mi, Y.J.; Zheng, L.S.; Wang, F.; She, Z.G.; Lin, Y.C.; To, K.K.; et al. Anthracenedione derivatives as anticancer agents isolated from secondary metabolites of the mangrove endophytic fungi. Mar. Drugs 2010, 8, 1469-1481.
17. Zhang, J.Y.; Liang, Y.J.; Chen, H.B.; Zheng, L.S.; Mi, Y.J.; Wang, F.; Zhao, X.Q.; Wang, X.K.; Zhang, H.; Fu, L.W. Structure identification of Euphorbia factor L3 and its induction of apoptosis through the mitochondrial pathway. Molecules 2011, 16, 3222-3223.
18. Zhang, J.Y.; Lin, M.T.; Yi, T.; Tang, Y.N.; Fan, L.L.; He, X.C.; Zhao, Z.Z.; Chen, H.B. Apoptosis sensitization by Euphorbia factor L1 in ABCB1-mediated multidrug resistant K562/ADR cells. Molecules 2013, 18, 12793-12808.